Literature DB >> 3337561

Intraoperative and external beam irradiation for locally advanced colorectal cancer.

L L Gunderson1, J K Martin, R W Bèart, D M Nagorney, J M Fieck, H S Wieand, A Martinez, M J O'Connell, J A Martenson, D C McIlrath.   

Abstract

In view of poor local control rates obtained with standard treatment, intraoperative radiation (IORT) using electrons was combined with external beam irradiation and surgical resection, with or without 5-fluorouracil (5FU), in 51 patients with locally advanced colorectal cancer (recurrent, 36 patients; primary, 15 patients). Patients received 4500-5500 cGy (rad) of fractionated, multiple field external beam irradiation and an IORT dose of 1000-2000 cGy. Thirty of 51 patients (59%) are alive and 22 patients (43%) are free of disease. In 44 patients at risk greater than or equal to 1 year, local progression within the IORT field has occurred in 1 of 44 (2%) and within the external beam field in 8 of 44 (18%). All local failures have occurred in patients with recurrence or with gross residual after partial resection, and the risk was less in patients who received 5FU during external irradiation (1 of 11, 9% vs. 6 of 31, 19%). The incidence of distant metastases is high in patients with recurrence, but subsequent peritoneal failures are infrequent. Acute and chronic tolerance have been acceptable, but peripheral nerve appears to be a dose-limiting structure. Randomized trials are needed to determine whether potential gains with IORT are real.

Entities:  

Mesh:

Year:  1988        PMID: 3337561      PMCID: PMC1493247          DOI: 10.1097/00000658-198801000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  Preoperative radiotherapy for adenocarcinoma of the rectosigmoid.

Authors:  K R Stevens; C V Allen; W S Fletcher
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

2.  Intraoperative radiotherapy: the Japanese experience.

Authors:  M Abe; M Takahashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-07       Impact factor: 7.038

3.  The dosimetric properties of an applicator system for intraoperative electron-beam therapy utilizing a Clinac-18 accelerator.

Authors:  E C McCullough; J A Anderson
Journal:  Med Phys       Date:  1982 Mar-Apr       Impact factor: 4.071

4.  Intraoperative irradiation: a pilot study combining external beam photons with "boost" dose intraoperative electrons.

Authors:  L L Gunderson; W U Shipley; H D Suit; E R Epp; G Nardi; W Wood; A Cohen; J Nelson; G Battit; P J Biggs; A Russell; A Rockett; D Clark
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

Review 5.  Current issues in the treatment of colorectal cancer.

Authors:  L L Gunderson; R W Beart; M J O'Connell
Journal:  Crit Rev Oncol Hematol       Date:  1986       Impact factor: 6.312

6.  Clinical experiences with intraoperative radiotherapy of locally advanced cancers.

Authors:  M Abe; M Takahashi; E Yabumoto; H Adachi; M Yoshii; K Mori
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

7.  Residual, inoperable or recurrent colorectal cancer. Interaction of surgery and radiotherapy.

Authors:  L L Gunderson; A M Cohen; C E Welch
Journal:  Am J Surg       Date:  1980-04       Impact factor: 2.565

8.  A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinoma.

Authors:  M J O'Connell; D S Childs; C G Moertel; M A Holbrook; A J Schutt; J Rubin; R E Ritts
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-07       Impact factor: 7.038

9.  Adjuvant cytotoxic liver perfusion for colorectal cancer.

Authors:  I Taylor; J Rowling; C West
Journal:  Br J Surg       Date:  1979-12       Impact factor: 6.939

10.  Tolerance of retroperitoneal structures to intraoperative radiation.

Authors:  W F Sindelar; J Tepper; E L Travis; R Terrill
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

View more
  9 in total

1.  Chemotherapy of Colorectal Cancer.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 2.  The role of intra-operative irradiation in locally advanced primary and recurrent rectal adenocarcinoma.

Authors:  L L Gunderson; M J O'Connell; R R Dozois
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

Review 3.  Advanced rectal cancer.

Authors:  J Alexander-Williams
Journal:  BMJ       Date:  1990-02-03

4.  Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven.

Authors:  Fabian A Holman; Michael G Haddock; Leonard L Gunderson; Miranda Kusters; Grard A P Nieuwenhuijzen; Hetty A van den Berg; Heidi Nelson; Harm J T Rutten
Journal:  J Gastrointest Oncol       Date:  2016-12

5.  Curative potential of multimodality therapy for locally recurrent rectal cancer.

Authors:  Dieter Hahnloser; Heidi Nelson; Leonard L Gunderson; Imran Hassan; Michael G Haddock; Michael J O'Connell; Stephen Cha; Daniel J Sargent; Alan Horgan
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 6.  External beam plus intraoperative irradiation for gastrointestinal cancers.

Authors:  L L Gunderson; D M Nagorney; J A Martenson; J H Donohue; G R Garton; H Nelson; J Fieck
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

7.  [Locally recurrent rectal cancer].

Authors:  A Troja; H R Raab
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

Review 8.  Pre-operative and post-operative radiotherapy and rectal cancer.

Authors:  L Påhlman; B Glimelius
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

9.  Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma.

Authors:  A M Lowy; T A Rich; J M Skibber; R A Dubrow; S A Curley
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.